Universal Scientific Revenue vs. Price To Sales
| 601231 Stock | 16.45 0.52 3.26% |
Total Revenue | First Reported 2012-03-31 | Previous Quarter 13.9 B | Current Value 16.6 B | Quarterly Volatility 5.1 B |
For Universal Scientific profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Universal Scientific to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Universal Scientific Industrial utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Universal Scientific's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Universal Scientific Industrial over time as well as its relative position and ranking within its peers.
Universal |
Universal Scientific Price To Sales vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Universal Scientific's current stock value. Our valuation model uses many indicators to compare Universal Scientific value to that of its competitors to determine the firm's financial worth. Universal Scientific Industrial is the top company in revenue category among its peers. It also is number one stock in price to sales category among its peers . The ratio of Revenue to Price To Sales for Universal Scientific Industrial is about 100,532,345,852 . At present, Universal Scientific's Total Revenue is projected to increase significantly based on the last few years of reporting. Comparative valuation analysis is a catch-all model that can be used if you cannot value Universal Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Universal Scientific's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Universal Revenue vs. Competition
Universal Scientific Industrial is the top company in revenue category among its peers. Market size based on revenue of Information Technology industry is presently estimated at about 831.57 Billion. Universal Scientific holds roughly 60.79 Billion in revenue claiming about 7% of equities under Information Technology industry.
Universal Price To Sales vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Universal Scientific |
| = | 60.79 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Universal Scientific |
| = | 0.60 X |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Universal Price To Sales Comparison
Universal Scientific is currently under evaluation in price to sales category among its peers.
Universal Scientific Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Universal Scientific, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Universal Scientific will eventually generate negative long term returns. The profitability progress is the general direction of Universal Scientific's change in net profit over the period of time. It can combine multiple indicators of Universal Scientific, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | 2.5 B | 1.3 B | |
| Income Before Tax | 2.2 B | 1.4 B | |
| Net Income Applicable To Common Shares | 3.5 B | 3.7 B | |
| Net Income | 1.9 B | 1.2 B | |
| Income Tax Expense | 479.8 M | 503.8 M | |
| Net Income From Continuing Ops | 1.9 B | 1.7 B | |
| Total Other Income Expense Net | 206.6 M | 128.6 M | |
| Net Interest Income | -180 M | -171 M | |
| Interest Income | 236.5 M | 248.4 M | |
| Change To Netincome | 156.4 M | 164.2 M |
Universal Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Universal Scientific. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Universal Scientific position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Universal Scientific's important profitability drivers and their relationship over time.
Use Universal Scientific in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Universal Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universal Scientific will appreciate offsetting losses from the drop in the long position's value.Universal Scientific Pair Trading
Universal Scientific Industrial Pair Trading Analysis
The ability to find closely correlated positions to Universal Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Universal Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Universal Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Universal Scientific Industrial to buy it.
The correlation of Universal Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Universal Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Universal Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Universal Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Universal Scientific position
In addition to having Universal Scientific in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Long/short ETFs Thematic Idea Now
Long/short ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Long/short ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Long/short ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Universal Stock
To fully project Universal Scientific's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Universal Scientific at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Universal Scientific's income statement, its balance sheet, and the statement of cash flows.